These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 22832328

  • 1. Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry.
    Choi J, Jung WH, Koo JS.
    Pathobiology; 2013; 80(1):41-52. PubMed ID: 22832328
    [Abstract] [Full Text] [Related]

  • 2. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.
    Vleugel MM, Shvarts D, van der Wall E, van Diest PJ.
    Hum Pathol; 2006 Aug; 37(8):1085-92. PubMed ID: 16867872
    [Abstract] [Full Text] [Related]

  • 3. The expression of metabolism-related proteins in phyllodes tumors.
    Kwon JE, Jung WH, Koo JS.
    Tumour Biol; 2013 Feb; 34(1):115-24. PubMed ID: 22986897
    [Abstract] [Full Text] [Related]

  • 4. The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype.
    Sousa B, Ribeiro AS, Nobre AR, Lopes N, Martins D, Pinheiro C, Vieira AF, Albergaria A, Gerhard R, Schmitt F, Baltazar F, Paredes J.
    BMC Cancer; 2014 Oct 01; 14():734. PubMed ID: 25269858
    [Abstract] [Full Text] [Related]

  • 5. Expression of cell metabolism-related genes in different molecular subtypes of triple-negative breast cancer.
    Jeon HM, Kim DH, Jung WH, Koo JS.
    Tumori; 2013 Oct 01; 99(4):555-64. PubMed ID: 24326847
    [Abstract] [Full Text] [Related]

  • 6. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
    Trastour C, Benizri E, Ettore F, Ramaioli A, Chamorey E, Pouysségur J, Berra E.
    Int J Cancer; 2007 Apr 01; 120(7):1451-8. PubMed ID: 17245699
    [Abstract] [Full Text] [Related]

  • 7. Fibrotic focus and hypoxia in male breast cancer.
    Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, Hinrichs B, van Diest PJ.
    Mod Pathol; 2012 Oct 01; 25(10):1397-404. PubMed ID: 22684218
    [Abstract] [Full Text] [Related]

  • 8. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
    Tan EY, Yan M, Campo L, Han C, Takano E, Turley H, Candiloro I, Pezzella F, Gatter KC, Millar EK, O'Toole SA, McNeil CM, Crea P, Segara D, Sutherland RL, Harris AL, Fox SB.
    Br J Cancer; 2009 Jan 27; 100(2):405-11. PubMed ID: 19165203
    [Abstract] [Full Text] [Related]

  • 9. [Significance of carbonic anhydrase IX protein expression in molecular subtyping of breast cancers].
    Li MP, Ren LF, Cai HG, Yang HY, Lu B, Zhang P, Bao L.
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar 27; 42(3):182-5. PubMed ID: 23769438
    [Abstract] [Full Text] [Related]

  • 10. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
    Doyen J, Trastour C, Ettore F, Peyrottes I, Toussant N, Gal J, Ilc K, Roux D, Parks SK, Ferrero JM, Pouysségur J.
    Biochem Biophys Res Commun; 2014 Aug 15; 451(1):54-61. PubMed ID: 25058459
    [Abstract] [Full Text] [Related]

  • 11. Alteration of REDD1-mediated mammalian target of rapamycin pathway and hypoxia-inducible factor-1α regulation in human breast cancer.
    Koo JS, Jung W.
    Pathobiology; 2010 Aug 15; 77(6):289-300. PubMed ID: 21266827
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
    Chen CL, Chu JS, Su WC, Huang SC, Lee WY.
    Virchows Arch; 2010 Jul 15; 457(1):53-61. PubMed ID: 20526721
    [Abstract] [Full Text] [Related]

  • 13. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.
    Sadlecki P, Bodnar M, Grabiec M, Marszalek A, Walentowicz P, Sokup A, Zegarska J, Walentowicz-Sadlecka M.
    Biomed Res Int; 2014 Jul 15; 2014():616850. PubMed ID: 24745019
    [Abstract] [Full Text] [Related]

  • 14. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
    Pinheiro C, Sousa B, Albergaria A, Paredes J, Dufloth R, Vieira D, Schmitt F, Baltazar F.
    Histol Histopathol; 2011 Oct 15; 26(10):1279-86. PubMed ID: 21870331
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M, Reddemann R, Said HM, Holzhausen HJ, Taubert H, Becker A, Kuhnt T, Hänsgen G, Dunst J, Vordermark D.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1481-7. PubMed ID: 17056190
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
    Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL.
    J Clin Oncol; 2001 Aug 15; 19(16):3660-8. PubMed ID: 11504747
    [Abstract] [Full Text] [Related]

  • 17. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer.
    Tan EY, Campo L, Han C, Turley H, Pezzella F, Gatter KC, Harris AL, Fox SB.
    Breast Cancer Res; 2007 Aug 15; 9(6):R89. PubMed ID: 18096060
    [Abstract] [Full Text] [Related]

  • 18. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
    Jankovic B, Aquino-Parsons C, Raleigh JA, Stanbridge EJ, Durand RE, Banath JP, MacPhail SH, Olive PL.
    Cytometry B Clin Cytom; 2006 Mar 15; 70(2):45-55. PubMed ID: 16456867
    [Abstract] [Full Text] [Related]

  • 19. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis.
    Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck EA.
    Breast Cancer Res Treat; 2003 Sep 15; 81(2):137-47. PubMed ID: 14572156
    [Abstract] [Full Text] [Related]

  • 20. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer.
    Shan X, Wang D, Chen J, Xiao X, Jiang Y, Wang Y, Fan Y.
    J Comput Assist Tomogr; 2013 Sep 15; 37(1):22-8. PubMed ID: 23321829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.